• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血脂与肌萎缩侧索硬化症的多基因关联。

Polygenic link between blood lipids and amyotrophic lateral sclerosis.

机构信息

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

出版信息

Neurobiol Aging. 2018 Jul;67:202.e1-202.e6. doi: 10.1016/j.neurobiolaging.2018.03.022. Epub 2018 Mar 27.

DOI:10.1016/j.neurobiolaging.2018.03.022
PMID:29685649
Abstract

Dyslipidemia is common among patients with amyotrophic lateral sclerosis (ALS). We aimed to test the association and causality between blood lipids and ALS, using polygenic analyses on the summary results of genome-wide association studies. Polygenic risk scores (PRSs) based on low-density lipoprotein cholesterol (LDL-C) and total cholesterol (TC) risk alleles were significantly associated with a higher risk of ALS. Using single nucleotide polymorphisms (SNPs) specifically associated with LDL-C and TC as the instrumental variables, statistically significant causal effects of LDL-C and TC on ALS risk were identified in Mendelian randomization analysis. No significant association was noted between PRSs based on triglycerides or high-density lipoprotein cholesterol risk alleles and ALS, and the PRSs based on ALS risk alleles were not associated with any studied lipids. This study supports that high levels of LDL-C and TC are risk factors for ALS, and it also suggests a causal relationship of LDL-C and TC to ALS.

摘要

血脂异常在肌萎缩侧索硬化症(ALS)患者中很常见。我们旨在通过对全基因组关联研究汇总结果的多基因分析来检验血脂与 ALS 之间的关联和因果关系。基于低密度脂蛋白胆固醇(LDL-C)和总胆固醇(TC)风险等位基因的多基因风险评分(PRS)与 ALS 风险的增加显著相关。使用与 LDL-C 和 TC 特异性相关的单核苷酸多态性(SNP)作为工具变量,在 Mendelian 随机化分析中鉴定出 LDL-C 和 TC 对 ALS 风险的统计学显著因果效应。基于甘油三酯或高密度脂蛋白胆固醇风险等位基因的 PRS 与 ALS 之间无显著相关性,并且基于 ALS 风险等位基因的 PRS 与任何研究的脂质均无相关性。这项研究支持高水平的 LDL-C 和 TC 是 ALS 的危险因素,并且还表明 LDL-C 和 TC 与 ALS 之间存在因果关系。

相似文献

1
Polygenic link between blood lipids and amyotrophic lateral sclerosis.血脂与肌萎缩侧索硬化症的多基因关联。
Neurobiol Aging. 2018 Jul;67:202.e1-202.e6. doi: 10.1016/j.neurobiolaging.2018.03.022. Epub 2018 Mar 27.
2
Lipids and amyotrophic lateral sclerosis: A two-sample Mendelian randomization study.脂类与肌萎缩侧索硬化症:两样本孟德尔随机化研究。
Eur J Neurol. 2023 Jul;30(7):1899-1906. doi: 10.1111/ene.15810. Epub 2023 Apr 19.
3
Causal effects of blood lipids on amyotrophic lateral sclerosis: a Mendelian randomization study.血脂对肌萎缩侧索硬化症的因果影响:一项孟德尔随机化研究。
Hum Mol Genet. 2019 Feb 15;28(4):688-697. doi: 10.1093/hmg/ddy384.
4
Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中的共享多基因风险和因果推断。
Ann Neurol. 2019 Apr;85(4):470-481. doi: 10.1002/ana.25431. Epub 2019 Mar 13.
5
Polygenic associations and causal inferences between serum immunoglobulins and amyotrophic lateral sclerosis.血清免疫球蛋白与肌萎缩侧索硬化症的多基因关联和因果推断。
Clin Chim Acta. 2021 Oct;521:131-136. doi: 10.1016/j.cca.2021.07.007. Epub 2021 Jul 8.
6
Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort.碳水化合物、脂质和载脂蛋白代谢的血液生物标志物与肌萎缩侧索硬化症的风险:对瑞典 AMORIS 队列超过 20 年的随访。
Ann Neurol. 2017 May;81(5):718-728. doi: 10.1002/ana.24936.
7
Association between genetically proxied lipid-lowering drug targets, lipid traits, and amyotrophic lateral sclerosis: a mendelian randomization study.降脂药物靶点的遗传相关性、血脂特征与肌萎缩侧索硬化症的关系:一项孟德尔随机化研究。
Acta Neurol Belg. 2024 Apr;124(2):485-494. doi: 10.1007/s13760-023-02393-w. Epub 2023 Oct 27.
8
Evaluation of the relationship between plasma lipids and abdominal aortic aneurysm: A Mendelian randomization study.评估血浆脂质与腹主动脉瘤之间的关系:一项孟德尔随机化研究。
PLoS One. 2018 Apr 12;13(4):e0195719. doi: 10.1371/journal.pone.0195719. eCollection 2018.
9
Common variants at 30 loci contribute to polygenic dyslipidemia.30个基因座上的常见变异导致多基因血脂异常。
Nat Genet. 2009 Jan;41(1):56-65. doi: 10.1038/ng.291. Epub 2008 Dec 7.
10
Genetic variation in targets of lipid-lowering drugs and amyotrophic lateral sclerosis risk: a Mendelian randomization study.降脂药物靶点的遗传变异与肌萎缩侧索硬化症风险:一项孟德尔随机化研究。
Amyotroph Lateral Scler Frontotemporal Degener. 2024 Feb;25(1-2):197-206. doi: 10.1080/21678421.2023.2255622. Epub 2023 Sep 9.

引用本文的文献

1
Lipid Metabolism and Statin Therapy in Neurodegenerative Diseases: An Endocrine View.神经退行性疾病中的脂质代谢与他汀类药物治疗:内分泌视角
Metabolites. 2025 Apr 18;15(4):282. doi: 10.3390/metabo15040282.
2
Association between cardiometabolic diseases and the risk and progression of motor neuron diseases in Sweden: a population-based case-control study.瑞典心脏代谢疾病与运动神经元疾病风险及进展之间的关联:一项基于人群的病例对照研究。
Lancet Reg Health Eur. 2024 Dec 10;49:101173. doi: 10.1016/j.lanepe.2024.101173. eCollection 2025 Feb.
3
Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTD.
肌萎缩侧索硬化症/额颞叶痴呆遗传风险升高的致病基因变异携带者临床管理指南
J Neurol Neurosurg Psychiatry. 2025 Jan 31;96(3). doi: 10.1136/jnnp-2024-334339.
4
Machine learning and biological validation identify sphingolipids as potential mediators of paclitaxel-induced neuropathy in cancer patients.机器学习和生物学验证将鞘脂类确定为癌症患者紫杉醇诱导神经病变的潜在介质。
Elife. 2024 Sep 30;13:RP91941. doi: 10.7554/eLife.91941.
5
Dysregulation of muscle cholesterol transport in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中肌肉胆固醇转运的失调
Brain. 2025 Mar 6;148(3):788-802. doi: 10.1093/brain/awae270.
6
The role of statins in amyotrophic lateral sclerosis: protective or not?他汀类药物在肌萎缩侧索硬化症中的作用:是否具有保护作用?
Front Neurosci. 2024 Jun 5;18:1422912. doi: 10.3389/fnins.2024.1422912. eCollection 2024.
7
Gut microbiome correlates with plasma lipids in amyotrophic lateral sclerosis.肠道微生物组与肌萎缩侧索硬化症患者的血浆脂质相关。
Brain. 2024 Feb 1;147(2):665-679. doi: 10.1093/brain/awad306.
8
Involvement of Lipids in the Pathogenesis of Amyotrophic Lateral Sclerosis.脂质在肌萎缩侧索硬化症发病机制中的作用
Life (Basel). 2023 Feb 12;13(2):510. doi: 10.3390/life13020510.
9
Protective Effects of Lovastatin in a Population-Based ALS Study and Mouse Model.洛伐他汀在一项基于人群的肌萎缩侧索硬化症研究及小鼠模型中的保护作用。
Ann Neurol. 2023 May;93(5):881-892. doi: 10.1002/ana.26600. Epub 2023 Jan 30.
10
Analysis of routine blood parameters in patients with amyotrophic lateral sclerosis and evaluation of a possible correlation with disease progression-a multicenter study.肌萎缩侧索硬化症患者常规血液参数分析及与疾病进展可能相关性的评估——一项多中心研究
Front Neurol. 2022 Jul 27;13:940375. doi: 10.3389/fneur.2022.940375. eCollection 2022.